New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

And last month, Science, the brain-machine interface startup run by former Neuralink President Max Hodak, announced the ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration-- and researchers now think they ...

The drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

A new study explains not only why some patients with wet age-related macular degeneration (or 'wet' AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used ...

TUESDAY, Nov. 5, 2024 (HealthDay News) -- Current treatments sometimes fail to help people with “wet” age-related macular ...

EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

Eating two ounces of unsalted pistachios daily for 12 days significantly improved the health of macular pigment optical ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables ...